<!DOCTYPE html>
<html lang="en">
<head>

<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">

<title>Kratom Adverse Event Reporting | FDA and Public Health Surveillance</title>

<meta name="description" content="Summary of publicly available adverse event reports and federal safety communications related to kratom (Mitragyna speciosa). Legislative and regulatory reference page.">

<meta name="keywords" content="kratom adverse events, kratom FDA reports, kratom CAERS, kratom safety data, mitragynine adverse effects, kratom toxicology">

<meta name="author" content="Kratom Regulatory Review">
<meta name="theme-color" content="#0c2d48">

<link rel="canonical" href="https://kratomregulatoryreview.org/adverse.html">

<!-- Google Analytics -->
<script async src="https://www.googletagmanager.com/gtag/js?id=G-MQKC65VZVY"></script>
<script async src="https://www.googletagmanager.com/gtag/js?id=G-P31PD1SSTD"></script>
<script>
window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config','G-MQKC65VZVY');
gtag('config','G-P31PD1SSTD');
</script>

<link rel="stylesheet" href="css/style.css">

<style>
.page-header { padding: 40px 0 25px 0; }
.page-intro { max-width: 850px; margin-bottom: 12px; line-height: 1.7; }
.page-note { max-width: 850px; font-size: 14px; color: #4b5563; margin-bottom: 15px; }

.accordion { max-width:1100px; margin:40px auto; }
.accordion-item { border:1px solid #e2e8f0; border-radius:12px; margin-bottom:18px; overflow:hidden; }
.accordion-header { background:#0c2d48; color:#fff; padding:18px; font-size:18px; font-weight:600; cursor:pointer; }
.accordion-content { display:none; padding:20px; background:#f9fafb; }

.case-list { list-style:none; padding:0; margin:0; display:grid; gap:16px; }

.data-card {
  border:1px solid #e2e8f0;
  border-radius:6px;
  padding:16px 20px;
  background:#ffffff;
}

.data-header {
  font-weight:600;
  font-size:16px;
  margin-bottom:6px;
}

.data-value {
  font-weight:700;
  font-size:20px;
}

.footer { background:#0c2d48; color:#fff; padding:30px 0; text-align:center; margin-top:40px; }
</style>

<script>
document.addEventListener("DOMContentLoaded", function(){
  const headers = document.querySelectorAll(".accordion-header");
  headers.forEach(header=>{
    header.addEventListener("click",()=>{
      const content = header.nextElementSibling;
      content.style.display = content.style.display === "block" ? "none" : "block";
    });
  });
});
</script>

</head>

<body>

<section class="page-header">
  <div class="container">
    <h1>Kratom Adverse Event Reporting</h1>

    <p class="page-intro">
      This page summarizes publicly available adverse event reports,
      federal safety communications, and clinical surveillance data
      related to kratom (<em>Mitragyna speciosa</em>) exposure.
    </p>

    <p class="page-note">
      Adverse event reporting systems collect voluntary submissions from
      clinicians, consumers, and manufacturers. These reports describe
      reported associations and do not independently establish causation.
    </p>
  </div>
</section>

<div class="accordion">

<!-- ================= FDA CAERS ================= -->

<div class="accordion-item">
<div class="accordion-header">
FDA CAERS Adverse Event Reports
</div>

<div class="accordion-content">

<div class="data-card">
  <div class="data-header">
    CFSAN Adverse Event Reporting System (CAERS)
  </div>
  <p style="font-size:14px; margin:0;">
    The FDA’s CAERS database collects reports involving foods
    and dietary supplements. Reports referencing kratom products
    have included serious medical outcomes such as hospitalization,
    liver injury, seizures, dependence, and deaths.
  </p>
</div>

<div class="data-card">
  <div class="data-header">
    Documented Reported Outcomes
  </div>
  <ul style="margin:0; padding-left:18px; font-size:14px;">
    <li>Hospitalizations following kratom ingestion</li>
    <li>Reported deaths in submitted adverse event cases</li>
    <li>Liver injury and elevated liver enzymes</li>
    <li>Seizures and neurologic events</li>
    <li>Substance use disorder and withdrawal symptoms</li>
  </ul>
</div>

<div style="margin-top:18px;">
  <a href="https://www.fda.gov/news-events/public-health-focus/fda-and-kratom"
     target="_blank"
     style="font-weight:600; color:#0c2d48; text-decoration:underline;">
     View FDA Kratom Safety Communications →
  </a>
</div>

</div>
</div>


<!-- ================= CLINICAL LITERATURE ================= -->

<div class="accordion-item">
<div class="accordion-header">
Clinical Case Reports and Literature Summaries
</div>

<div class="accordion-content">

<div class="data-card">
  <div class="data-header">Reported Clinical Effects</div>
  <ul style="margin:0; padding-left:18px; font-size:14px;">
    <li>Hepatic injury (liver inflammation, cholestasis)</li>
    <li>Neurologic complications (seizure, altered mental status)</li>
    <li>Psychiatric disturbance (psychosis, paranoia)</li>
    <li>Cardiovascular effects (tachycardia, arrhythmias)</li>
    <li>Gastrointestinal symptoms (nausea, vomiting, constipation)</li>
  </ul>
</div>

<div class="data-card">
  <div class="data-header">Limitations of Current Reporting</div>
  <p style="font-size:14px; margin:0;">
    Many reports involve co-ingestion of other substances,
    potential contamination, or incomplete toxicology data.
    Adverse event reports do not provide incidence rates
    and are not designed to establish direct causality.
  </p>
</div>

</div>
</div>


<!-- ================= PUBLIC HEALTH CONTEXT ================= -->

<div class="accordion-item">
<div class="accordion-header">
Public Health Context
</div>

<div class="accordion-content">

<div class="data-card">
  <p style="font-size:14px; margin:0;">
    The U.S. Food and Drug Administration has issued multiple
    public safety communications regarding kratom products,
    citing concerns about contamination, toxicity, and
    substance use disorder risk. There are currently no
    FDA-approved kratom products in U.S. commerce.
  </p>
</div>

</div>
</div>

</div>

<footer class="footer">
  <div class="container">
    <p>© 2026 Kratom Regulatory Review</p>
  </div>
</footer>

</body>
</html>
